HEADER HYDROLASE/INHIBITOR 03-JUL-23 8JYG TITLE CRYSTAL STRUCTURE OF HUMAN HPSE1 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPARANASE 50 KDA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 EC: 3.2.1.166; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HEPARANASE; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: ENDO-GLUCORONIDASE,HEPARANASE-1,HPA1; COMPND 11 EC: 3.2.1.166; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: HPSE, HEP, HPA, HPA1, HPR1, HPSE1, HSE1; SOURCE 13 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS ENDO-GLUCORONIDASE, HEPARANASE-1, HEP, HPA, HPA1, HPR1, HPSE1, HSE1, KEYWDS 2 HYDROLASE, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.MIMA,N.FUJIMOTO,Y.IMAI REVDAT 1 20-SEP-23 8JYG 0 JRNL AUTH Y.IMAI,R.SUZUKI,D.WAKASUGI,D.MATSUDA,N.TANAKA-YAMAMOTO, JRNL AUTH 2 Y.OHKI,M.MIMA,M.ENDO,R.TABATA,H.MATSUZAWA,Y.HASEGAWA,S.KATO, JRNL AUTH 3 M.SUGISAKI,H.MIYAGAWA,N.FUJIMOTO,T.FUKUNAGA,S.KATO, JRNL AUTH 4 T.TAKAHASHI,H.KAKINUMA JRNL TITL STRUCTURE-BASED LEAD OPTIMIZATION TO IMPROVE POTENCY AND JRNL TITL 2 SELECTIVITY OF A NOVEL JRNL TITL 3 TETRAHYDROIMIDAZO[1,2-A]PYRIDINE-5-CARBOXYLIC ACID SERIES OF JRNL TITL 4 HEPARANASE-1 INHIBITOR. JRNL REF BIOORG.MED.CHEM. V. 93 17460 2023 JRNL REFN ESSN 1464-3391 JRNL PMID 37660465 JRNL DOI 10.1016/J.BMC.2023.117460 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 32605 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.907 REMARK 3 FREE R VALUE TEST SET COUNT : 1600 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2254 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.79 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE SET COUNT : 134 REMARK 3 BIN FREE R VALUE : 0.2730 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3644 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 146 REMARK 3 SOLVENT ATOMS : 208 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.67800 REMARK 3 B22 (A**2) : -3.10900 REMARK 3 B33 (A**2) : 3.28200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.31300 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.174 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.153 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.128 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.914 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.951 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3862 ; 0.009 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3750 ; 0.001 ; 0.015 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5193 ; 1.582 ; 1.675 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8628 ; 1.273 ; 1.595 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 458 ; 7.204 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 181 ;33.751 ;21.823 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 643 ;14.579 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;21.087 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 478 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4231 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 890 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 790 ; 0.201 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 77 ; 0.217 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1860 ; 0.168 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 206 ; 0.170 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1838 ; 2.593 ; 3.181 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1837 ; 2.570 ; 3.177 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2294 ; 3.935 ; 4.757 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2295 ; 3.939 ; 4.761 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2024 ; 3.200 ; 3.605 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2025 ; 3.199 ; 3.606 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2899 ; 4.948 ; 5.221 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2900 ; 4.948 ; 5.222 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 8JYG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1300039123. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00003 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32623 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 77.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 5E8M REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% W/V POLYETHYLENE GLYCOL 3,350, 100 REMARK 280 MM BIS-TRIS PH 5.5, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.52450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 158 REMARK 465 LYS A 159 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 258 33.85 -85.96 REMARK 500 LYS A 274 68.50 -151.40 REMARK 500 THR A 333 -42.87 -132.62 REMARK 500 GLU A 343 118.57 -162.62 REMARK 500 SER A 345 -168.77 -161.31 REMARK 500 LEU A 355 -51.38 -125.83 REMARK 500 LEU A 419 -153.94 -118.52 REMARK 500 ARG A 428 88.82 -151.21 REMARK 500 PRO A 469 37.15 -98.36 REMARK 500 ALA B 90 149.29 -170.01 REMARK 500 PHE B 101 24.61 -144.47 REMARK 500 REMARK 500 REMARK: NULL DBREF 8JYG A 158 543 UNP Q9Y251 HPSE_HUMAN 158 543 DBREF 8JYG B 35 109 UNP Q9Y251 HPSE_HUMAN 35 109 SEQADV 8JYG ARG A 307 UNP Q9Y251 LYS 307 ENGINEERED MUTATION SEQADV 8JYG ALA B 34 UNP Q9Y251 EXPRESSION TAG SEQRES 1 A 386 LYS LYS PHE LYS ASN SER THR TYR SER ARG SER SER VAL SEQRES 2 A 386 ASP VAL LEU TYR THR PHE ALA ASN CYS SER GLY LEU ASP SEQRES 3 A 386 LEU ILE PHE GLY LEU ASN ALA LEU LEU ARG THR ALA ASP SEQRES 4 A 386 LEU GLN TRP ASN SER SER ASN ALA GLN LEU LEU LEU ASP SEQRES 5 A 386 TYR CYS SER SER LYS GLY TYR ASN ILE SER TRP GLU LEU SEQRES 6 A 386 GLY ASN GLU PRO ASN SER PHE LEU LYS LYS ALA ASP ILE SEQRES 7 A 386 PHE ILE ASN GLY SER GLN LEU GLY GLU ASP PHE ILE GLN SEQRES 8 A 386 LEU HIS LYS LEU LEU ARG LYS SER THR PHE LYS ASN ALA SEQRES 9 A 386 LYS LEU TYR GLY PRO ASP VAL GLY GLN PRO ARG ARG LYS SEQRES 10 A 386 THR ALA LYS MET LEU LYS SER PHE LEU LYS ALA GLY GLY SEQRES 11 A 386 GLU VAL ILE ASP SER VAL THR TRP HIS HIS TYR TYR LEU SEQRES 12 A 386 ASN GLY ARG THR ALA THR ARG GLU ASP PHE LEU ASN PRO SEQRES 13 A 386 ASP VAL LEU ASP ILE PHE ILE SER SER VAL GLN LYS VAL SEQRES 14 A 386 PHE GLN VAL VAL GLU SER THR ARG PRO GLY LYS LYS VAL SEQRES 15 A 386 TRP LEU GLY GLU THR SER SER ALA TYR GLY GLY GLY ALA SEQRES 16 A 386 PRO LEU LEU SER ASP THR PHE ALA ALA GLY PHE MET TRP SEQRES 17 A 386 LEU ASP LYS LEU GLY LEU SER ALA ARG MET GLY ILE GLU SEQRES 18 A 386 VAL VAL MET ARG GLN VAL PHE PHE GLY ALA GLY ASN TYR SEQRES 19 A 386 HIS LEU VAL ASP GLU ASN PHE ASP PRO LEU PRO ASP TYR SEQRES 20 A 386 TRP LEU SER LEU LEU PHE LYS LYS LEU VAL GLY THR LYS SEQRES 21 A 386 VAL LEU MET ALA SER VAL GLN GLY SER LYS ARG ARG LYS SEQRES 22 A 386 LEU ARG VAL TYR LEU HIS CYS THR ASN THR ASP ASN PRO SEQRES 23 A 386 ARG TYR LYS GLU GLY ASP LEU THR LEU TYR ALA ILE ASN SEQRES 24 A 386 LEU HIS ASN VAL THR LYS TYR LEU ARG LEU PRO TYR PRO SEQRES 25 A 386 PHE SER ASN LYS GLN VAL ASP LYS TYR LEU LEU ARG PRO SEQRES 26 A 386 LEU GLY PRO HIS GLY LEU LEU SER LYS SER VAL GLN LEU SEQRES 27 A 386 ASN GLY LEU THR LEU LYS MET VAL ASP ASP GLN THR LEU SEQRES 28 A 386 PRO PRO LEU MET GLU LYS PRO LEU ARG PRO GLY SER SER SEQRES 29 A 386 LEU GLY LEU PRO ALA PHE SER TYR SER PHE PHE VAL ILE SEQRES 30 A 386 ARG ASN ALA LYS VAL ALA ALA CYS ILE SEQRES 1 B 76 ALA ALA GLN ASP VAL VAL ASP LEU ASP PHE PHE THR GLN SEQRES 2 B 76 GLU PRO LEU HIS LEU VAL SER PRO SER PHE LEU SER VAL SEQRES 3 B 76 THR ILE ASP ALA ASN LEU ALA THR ASP PRO ARG PHE LEU SEQRES 4 B 76 ILE LEU LEU GLY SER PRO LYS LEU ARG THR LEU ALA ARG SEQRES 5 B 76 GLY LEU SER PRO ALA TYR LEU ARG PHE GLY GLY THR LYS SEQRES 6 B 76 THR ASP PHE LEU ILE PHE ASP PRO LYS LYS GLU HET V8R A 601 30 HET EDO A 602 4 HET EDO A 603 4 HET EDO A 604 4 HET EDO A 605 4 HET EDO A 606 4 HET EDO A 607 4 HET EDO A 608 4 HET EDO A 609 4 HET EDO A 610 4 HET EDO A 611 4 HET EDO A 612 4 HET EDO A 613 4 HET EDO A 614 4 HET EDO A 615 4 HET EDO A 616 4 HET NAG A 617 14 HET NAG A 618 14 HET EDO A 619 4 HET EDO A 620 4 HET EDO A 621 4 HET EDO A 622 4 HET EDO A 623 4 HET EDO A 624 4 HET EDO A 625 4 HETNAM V8R (5~{S},6~{R},7~{S},8~{S})-6,7,8-TRIS(OXIDANYL)-2-[2-(3- HETNAM 2 V8R PHENOXYPHENYL)ETHYL]-5,6,7,8-TETRAHYDROIMIDAZO[1,2- HETNAM 3 V8R A]PYRIDINE-5-CARBOXYLIC ACID HETNAM EDO 1,2-ETHANEDIOL HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN EDO ETHYLENE GLYCOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 V8R C22 H22 N2 O6 FORMUL 4 EDO 22(C2 H6 O2) FORMUL 19 NAG 2(C8 H15 N O6) FORMUL 28 HOH *208(H2 O) HELIX 1 AA1 SER A 166 GLY A 181 1 16 HELIX 2 AA2 SER A 201 LYS A 214 1 14 HELIX 3 AA3 GLU A 225 ASN A 227 5 3 HELIX 4 AA4 SER A 228 ASP A 234 1 7 HELIX 5 AA5 ASN A 238 LYS A 255 1 18 HELIX 6 AA6 THR A 275 GLY A 287 1 13 HELIX 7 AA7 GLU A 288 ILE A 290 5 3 HELIX 8 AA8 THR A 306 LEU A 311 1 6 HELIX 9 AA9 ASN A 312 ARG A 334 1 23 HELIX 10 AB1 THR A 358 ALA A 360 5 3 HELIX 11 AB2 ALA A 361 GLY A 376 1 16 HELIX 12 AB3 LEU A 401 LEU A 413 1 13 HELIX 13 AB4 HIS A 486 SER A 490 5 5 HELIX 14 AB5 VAL A 539 ILE A 543 5 5 HELIX 15 AB6 ALA B 34 GLN B 36 5 3 HELIX 16 AB7 ASN B 64 ASP B 68 5 5 HELIX 17 AB8 ARG B 70 GLY B 76 1 7 HELIX 18 AB9 SER B 77 GLY B 86 1 10 HELIX 19 AC1 GLY B 96 ASP B 100 5 5 SHEET 1 AA1 2 SER A 163 TYR A 165 0 SHEET 2 AA1 2 LEU B 102 PHE B 104 1 O ILE B 103 N SER A 163 SHEET 1 AA2 8 SER A 219 LEU A 222 0 SHEET 2 AA2 8 LEU A 182 LEU A 188 1 N PHE A 186 O SER A 219 SHEET 3 AA2 8 ALA B 90 GLY B 95 1 O PHE B 94 N ILE A 185 SHEET 4 AA2 8 LEU B 57 ASP B 62 1 N VAL B 59 O TYR B 91 SHEET 5 AA2 8 VAL A 379 ARG A 382 1 N VAL A 380 O SER B 58 SHEET 6 AA2 8 LYS A 338 TYR A 348 1 N LEU A 341 O VAL A 379 SHEET 7 AA2 8 SER A 292 ASN A 301 1 N VAL A 293 O TRP A 340 SHEET 8 AA2 8 TYR A 264 VAL A 268 1 N VAL A 268 O HIS A 296 SHEET 1 AA3 4 LEU A 498 THR A 499 0 SHEET 2 AA3 4 VAL A 493 LEU A 495 -1 N LEU A 495 O LEU A 498 SHEET 3 AA3 4 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA3 4 LYS A 514 LEU A 516 -1 O LEU A 516 N VAL A 475 SHEET 1 AA4 8 LEU A 498 THR A 499 0 SHEET 2 AA4 8 VAL A 493 LEU A 495 -1 N LEU A 495 O LEU A 498 SHEET 3 AA4 8 VAL A 475 PRO A 482 -1 N ARG A 481 O GLN A 494 SHEET 4 AA4 8 SER A 528 ILE A 534 -1 O PHE A 531 N TYR A 478 SHEET 5 AA4 8 LEU A 450 ASN A 456 -1 N LEU A 452 O PHE A 532 SHEET 6 AA4 8 LEU A 431 THR A 438 -1 N HIS A 436 O THR A 451 SHEET 7 AA4 8 VAL A 414 VAL A 418 -1 N GLY A 415 O CYS A 437 SHEET 8 AA4 8 HIS B 50 LEU B 51 -1 O HIS B 50 N VAL A 418 SHEET 1 AA5 4 MET A 420 VAL A 423 0 SHEET 2 AA5 4 VAL B 38 PHE B 44 -1 O PHE B 44 N MET A 420 SHEET 3 AA5 4 LYS A 462 ARG A 465 1 N TYR A 463 O VAL B 39 SHEET 4 AA5 4 LEU A 522 LEU A 524 -1 O LEU A 522 N LEU A 464 SSBOND 1 CYS A 437 CYS A 542 1555 1555 2.02 LINK ND2 ASN A 238 C1 NAG A 617 1555 1555 1.45 LINK ND2 ASN A 459 C1 NAG A 618 1555 1555 1.46 CISPEP 1 GLY A 265 PRO A 266 0 -1.56 CISPEP 2 GLN A 383 VAL A 384 0 -13.27 CISPEP 3 TYR A 468 PRO A 469 0 -1.41 CISPEP 4 GLY A 484 PRO A 485 0 4.62 CISPEP 5 SER B 88 PRO B 89 0 -6.89 CRYST1 44.380 71.049 78.280 90.00 98.09 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022533 0.000000 0.003203 0.00000 SCALE2 0.000000 0.014075 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012903 0.00000